Telmisartan decreases inflammation by modulating TNF-α, IL-10, and RANK/RANKL in a rat model of ulcerative colitis

Pharmacological Reports

Volumn 67, Issue 3, 2015, Pages 520-526

  Guerra, Gerlane C B ^a   Araújo, Aurigena A ^a   Lira, George A ^a   Melo, Maryanne N ^b   Souto, Késia K O ^a   Fernandes, Daline ^c   Silva, Arthur L ^a   Júnior, Raimundo F Araújo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

Angiotensin II receptor blockers; Antiinflammatory; Immunohistochemical; Rats

Indexed keywords

INTERLEUKIN 10; MALONALDEHYDE; MYELOPEROXIDASE; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SALAZOSULFAPYRIDINE; TELMISARTAN; TUMOR NECROSIS FACTOR ALPHA; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNOMODULATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; ULCERATIVE COLITIS; ANIMAL; COLITIS, ULCERATIVE; DISEASE MODEL; DOSE RESPONSE; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BENZIMIDAZOLES; BENZOATES; COLITIS, ULCERATIVE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INFLAMMATION; INTERLEUKIN-10; RANK LIGAND; RATS; RATS, WISTAR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922511284     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2014.12.011     Document Type: Article

References (30)

1. N.A. Molodecky, I.S. Soon, D.M. Rabi, W.A. Ghali, M. Ferris, and G. Chernoff Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review Gastroenterology 142 1 2012 46 54 e42; quiz e30
2. D. Lissner, and B. Siegmund Ulcerative colitis: current and future treatment strategies Dig Dis 31 1 2013 91 94
3. S. Ben-Horin, U. Kopylov, and Y. Chowers Optimizing anti-TNF treatments in inflammatory bowel disease Autoimmun Rev 13 1 2014 24 30
4. A. Nakano, Y. Hattori, C. Aoki, T. Jojima, and K. Kasai Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma Hypertens Res 32 9 2009 765 769
5. A.A. Araujo, T.O. Souza, L.M. Moura, G.A. Brito, K.S. Aragao, and L.S. Araujo Effect of telmisartan on levels of IL-1, TNF-alpha, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model J Clin Periodontol 40 12 2013 1104 1111
6. H.H. Arab, M.Y. Al-Shorbagy, D.M. Abdallah, and N.N. Nassar Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease PLoS ONE 9 5 2014 e97193
7. W.C. Lim, S.B. Hanauer, and Y.C. Li Mechanisms of disease: vitamin D and inflammatory bowel disease Nat Clin Pract Gastroentrol Hepatol 2 7 2005 308 315
8. T. Totsuka, T. Kanai, Y. Nemoto, T. Tomita, R. Okamoto, and K. Tsuchiya RANK-RANKL signaling pathway is critically involved in the function of CD4(+)CD25(+) regulatory T cells in chronic colitis J Immunol 182 10 2009 6079 6087
9. B.R. MacPherson, and C.J. Pfeiffer Experimental production of diffuse colitis in rats Digestion 17 2 1978 135 150
10. A.D. Millar, D.S. Rampton, C.L. Chander, A.W. Claxson, S. Blades, and A. Coumbe Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis Gut 39 3 1996 407 415
11. C.J. Bell, D.G. Gall, and J.L. Wallace Disruption of colonic electrolyte transport in experimental colitis Am J Physiol 268 4 Pt 1 1995 G622 G630
12. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity - assessment of inflammation in rat and hamster models Gastroenterology 87 6 1984 1344 1350
13. H. Esterbauer, and K.H. Cheeseman Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal Methods Enzymol 186 1990 407 421
14. B. Safieh-Garabedian, S. Poole, A. Allchorne, J. Winter, and C.J. Woolf Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia Br J Pharmacol 115 7 1995 1265 1275
15. C. Kendall, I. Ionescu-Matiu, and G.R. Dreesman Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA) J Immunol Methods 56 3 1983 329 339
16. W.L. Zea-Iriarte, K. Makiyama, S. Goto, K. Murase, Y. Urata, and I. Sekine Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats - protective effect of rebamipide Scand J Gastroenterol 31 10 1996 985 992
17. Y. Naito, T. Takagi, and T. Yoshikawa Neutrophil-dependent oxidative stress in ulcerative colitis J Clin Biochem Nutr 41 1 2007 18 26
18. D.K. Podolsky Inflammatory bowel disease N Engl J Med 347 6 2002 417 429
19. A.P. Dijk, Z.J. Keuskamp, J.H. Wilson, and F.J. Zijlstra Sequential release of cytokines, lipid mediators and nitric oxide in experimental colitis Mediat Inflamm 4 3 1995 186 190
20. D. Closa, and E. Folch-Puy Oxygen free radicals and the systemic inflammatory response IUBMB Life 56 4 2004 185 191
21. M.N. Tzatzarakis, A.M. Tsatsakis, M.M. Lotter, M.I. Shtilman, and D.J. Vakalounakis Effect of novel water-soluble polymeric forms of sorbic acid against Fusarium oxysporum f.sp. radicis-cucumerinum Food Addit Contam 17 12 2000 965 971
22. M. Bitiren, A.Z. Karakilcik, M. Zerin, I. Ozardali, S. Selek, and Y. Nazligul Protective effects of selenium and vitamin E combination on experimental colitis in blood plasma and colon of rats Biol Trace Elem Res 136 1 2010 87 95
23. S.S. Al-Rejaie, H.M. Abuohashish, M.M. Al-Enazi, A.H. Al-Assaf, M.Y. Parmar, and M.M. Ahmed Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats World J Gastroenterol 19 34 2013 5633 5644
24. G. D'Argenio, G. Mazzone, C. Tuccillo, M.T. Ribecco, G. Graziani, and A.G. Gravina Apple polyphenols extract (APE) improves colon damage in a rat model of colitis Dig Liver Dis 44 7 2012 555 562
25. R.M. Hartmann, M.I. Morgan Martins, J. Tieppo, H.S. Fillmann, and N.P. Marroni Effect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acid Dig Dis Sci 57 8 2012 2038 2044
26. H.S. El-Abhar, L.N. Hammad, and H.S. Gawad Modulating effect of ginger extract on rats with ulcerative colitis J Ethnopharmacol 118 3 2008 367 372
27. S.V. Popov, P.A. Markov, I.R. Nikitina, S. Petrishev, V. Smirnov, and Y.S. Ovodov Preventive effect of a pectic polysaccharide of the common cranberry Vaccinium oxycoccos L. on acetic acid-induced colitis in mice World J Gastroenterol 12 41 2006 6646 6651
28. S.S. Al-Rejaie, H.M. Abuohashish, M.M. Ahmed, A.M. Aleisa, and O. Alkhamees Possible biochemical effects following inhibition of ethanol-induced gastric mucosa damage by Gymnema sylvestre in male Wistar albino rats Pharm Biol 50 12 2012 1542 1550
29. B.E. Sands Therapy of inflammatory bowel disease Gastroenterology 118 2 Suppl. 1 2000 S68 S82
30. J. Maul, and M. Zeitz Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations Langenbecks Arch Surg 397 1 2012 1 10